Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00006864
Recruitment Status : Completed
First Posted : June 2, 2003
Last Update Posted : January 9, 2014
National Cancer Institute (NCI)
Chiron Corporation
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2007
  Study Completion Date : July 2007